Microbiome Connect: Human EU event, 11th – 12th November 2020
Designing Microbiome-Modulating Therapeutics and Diagnostics for the Treatment of Neurological, Cancer, Metabolic and Gastro-Intestinal Indications.
Previously known as European Microbiome Congress, Microbiome Connect: Human EU is all about connecting leading academics and biotech companies presenting preclinical and clinical data, to network, educate and share knowledge.
Date and time: London, UK 11-12 November 2020
The gut microbiome is becoming an increasingly important druggable target for pharma companies through a range of modalities from FMT to small molecule and even phage.
Join key opinion leaders and 50+ expert speakers across three dedicated tracks of content to examine the latest preclinical and clinical data in extra-intestinal and intestinal indications. This is your opportunity to find out how others plan on translating gut-microbiome research into therapeutics that have the power to treat Oncological, Neurological, Gastro-Intestinal & Metabolic diseases.
Please note: If this event cannot run as a live event, the organisers will pivot to a virtual event on the same dates, with the same speakers and sessions, using an online platform.
Find out more about this event and register on the Microbiome Connect: Human EU website.